The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparing clinicopathologic feature and treatment outcome of patients who underwent surgical resection or liver transplant for nonalcoholic fatty liver disease (NAFLD)-related and non-NAFLD related hepatocellular carcinoma (HCC).
 
Surendra Pal Chaudhary
No Relationships to Disclose
 
Lipika Goyal
Consulting or Advisory Role - Agios; Alentis Therapeutics; AstraZeneca; Debiopharm Group; H3 Biomedicine; Klus Pharma; QED Therapeutics; Taiho Pharmaceutical
Research Funding - Taiho Pharmaceutical
Travel, Accommodations, Expenses - Debiopharm Group; Taiho Pharmaceutical
 
Matthew L Chase
No Relationships to Disclose
 
Andrew X. Zhu
Consulting or Advisory Role - AstraZeneca; Bayer; Eisai; Exelixis; Lilly; Merck; Roche/Genentech
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst)
 
Nikroo Hashemi
No Relationships to Disclose
 
Stephanie Reyes
No Relationships to Disclose
 
Kathleen E Corey
Consulting or Advisory Role - Gilead Sciences; Novo Nordisk
 
Joseph Misdraji
No Relationships to Disclose
 
Jeffrey William Clark
Consulting or Advisory Role - Emas pharma
Research Funding - Pfizer (Inst)